Global and United States Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027
SKU ID : QYR-18789277 | Publishing Date : 23-Jul-2021 | No. of pages : 128
Detailed TOC of Global and United States Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Passive Transdermal Drug Delivery
1.2.3 Active Transdermal Drug Delivery
1.3 Market by Application
1.3.1 Global Transmucosal Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transmucosal Drug Delivery Market Perspective (2016-2027)
2.2 Transmucosal Drug Delivery Growth Trends by Regions
2.2.1 Transmucosal Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transmucosal Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Transmucosal Drug Delivery Industry Dynamic
2.3.1 Transmucosal Drug Delivery Market Trends
2.3.2 Transmucosal Drug Delivery Market Drivers
2.3.3 Transmucosal Drug Delivery Market Challenges
2.3.4 Transmucosal Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transmucosal Drug Delivery Players by Revenue
3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
3.4 Global Transmucosal Drug Delivery Market Concentration Ratio
3.4.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2020
3.5 Transmucosal Drug Delivery Key Players Head office and Area Served
3.6 Key Players Transmucosal Drug Delivery Product Solution and Service
3.7 Date of Enter into Transmucosal Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transmucosal Drug Delivery Breakdown Data by Type
4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027)
5 Transmucosal Drug Delivery Breakdown Data by Application
5.1 Global Transmucosal Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Transmucosal Drug Delivery Market Size (2016-2027)
6.2 North America Transmucosal Drug Delivery Market Size by Type
6.2.1 North America Transmucosal Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Transmucosal Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Transmucosal Drug Delivery Market Size by Type (2016-2027)
6.3 North America Transmucosal Drug Delivery Market Size by Application
6.3.1 North America Transmucosal Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Transmucosal Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Transmucosal Drug Delivery Market Size by Application (2016-2027)
6.4 North America Transmucosal Drug Delivery Market Size by Country
6.4.1 North America Transmucosal Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Transmucosal Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Transmucosal Drug Delivery Market Size (2016-2027)
7.2 Europe Transmucosal Drug Delivery Market Size by Type
7.2.1 Europe Transmucosal Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Transmucosal Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Transmucosal Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Transmucosal Drug Delivery Market Size by Application
7.3.1 Europe Transmucosal Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Transmucosal Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Transmucosal Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Transmucosal Drug Delivery Market Size by Country
7.4.1 Europe Transmucosal Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Transmucosal Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Transmucosal Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Transmucosal Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Transmucosal Drug Delivery Market Size (2016-2027)
9.2 Latin America Transmucosal Drug Delivery Market Size by Type
9.2.1 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Transmucosal Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Transmucosal Drug Delivery Market Size by Application
9.3.1 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Transmucosal Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Transmucosal Drug Delivery Market Size by Country
9.4.1 Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transmucosal Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Transmucosal Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3M Pharmaceuticals
11.1.1 3M Pharmaceuticals Company Details
11.1.2 3M Pharmaceuticals Business Overview
11.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
11.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.1.5 3M Pharmaceuticals Recent Development
11.2 Acrux Limited
11.2.1 Acrux Limited Company Details
11.2.2 Acrux Limited Business Overview
11.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
11.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.2.5 Acrux Limited Recent Development
11.3 ALZA Corporation
11.3.1 ALZA Corporation Company Details
11.3.2 ALZA Corporation Business Overview
11.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
11.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.3.5 ALZA Corporation Recent Development
11.4 Antares Pharma, Inc.
11.4.1 Antares Pharma, Inc. Company Details
11.4.2 Antares Pharma, Inc. Business Overview
11.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
11.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.4.5 Antares Pharma, Inc. Recent Development
11.5 Apricus BioSciences, Inc
11.5.1 Apricus BioSciences, Inc Company Details
11.5.2 Apricus BioSciences, Inc Business Overview
11.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
11.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.5.5 Apricus BioSciences, Inc Recent Development
11.6 Aveva Drug Delivery Systems
11.6.1 Aveva Drug Delivery Systems Company Details
11.6.2 Aveva Drug Delivery Systems Business Overview
11.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
11.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.6.5 Aveva Drug Delivery Systems Recent Development
11.7 Corium International, Inc
11.7.1 Corium International, Inc Company Details
11.7.2 Corium International, Inc Business Overview
11.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
11.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.7.5 Corium International, Inc Recent Development
11.8 DURECT Corporation
11.8.1 DURECT Corporation Company Details
11.8.2 DURECT Corporation Business Overview
11.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
11.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.8.5 DURECT Corporation Recent Development
11.9 Generex Biotechnology Corporation
11.9.1 Generex Biotechnology Corporation Company Details
11.9.2 Generex Biotechnology Corporation Business Overview
11.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
11.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.9.5 Generex Biotechnology Corporation Recent Development
11.10 Inovio Pharmaceuticals, Inc.
11.10.1 Inovio Pharmaceuticals, Inc. Company Details
11.10.2 Inovio Pharmaceuticals, Inc. Business Overview
11.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.10.5 Inovio Pharmaceuticals, Inc. Recent Development
11.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
11.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
11.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
11.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
11.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
11.12 MedPharm LTD
11.12.1 MedPharm LTD Company Details
11.12.2 MedPharm LTD Business Overview
11.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
11.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.12.5 MedPharm LTD Recent Development
11.13 Mylan, Inc.
11.13.1 Mylan, Inc. Company Details
11.13.2 Mylan, Inc. Business Overview
11.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
11.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.13.5 Mylan, Inc. Recent Development
11.14 Nemaura Pharma Ltd
11.14.1 Nemaura Pharma Ltd Company Details
11.14.2 Nemaura Pharma Ltd Business Overview
11.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
11.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.14.5 Nemaura Pharma Ltd Recent Development
11.15 Nitto Denko Corporation
11.15.1 Nitto Denko Corporation Company Details
11.15.2 Nitto Denko Corporation Business Overview
11.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
11.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.15.5 Nitto Denko Corporation Recent Development
11.16 Noven Pharmaceuticals, Inc.
11.16.1 Noven Pharmaceuticals, Inc. Company Details
11.16.2 Noven Pharmaceuticals, Inc. Business Overview
11.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
11.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.16.5 Noven Pharmaceuticals, Inc. Recent Development
11.17 Pantec Biosolutions AG
11.17.1 Pantec Biosolutions AG Company Details
11.17.2 Pantec Biosolutions AG Business Overview
11.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
11.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.17.5 Pantec Biosolutions AG Recent Development
11.18 Tapemark
11.18.1 Tapemark Company Details
11.18.2 Tapemark Business Overview
11.18.3 Tapemark Transmucosal Drug Delivery Introduction
11.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.18.5 Tapemark Recent Development
11.18 tesa Labtec GmbH
.1 tesa Labtec GmbH Company Details
.2 tesa Labtec GmbH Business Overview
.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021)
.5 tesa Labtec GmbH Recent Development
11.20 TEVA Pharmaceutical Industries Ltd.
11.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
11.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
11.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
11.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
11.21 Zosano Pharma
11.21.1 Zosano Pharma Company Details
11.21.2 Zosano Pharma Business Overview
11.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
11.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021)
11.21.5 Zosano Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global and United States Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Transmucosal Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Passive Transdermal Drug Delivery
Table 3. Key Players of Active Transdermal Drug Delivery
Table 4. Global Transmucosal Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Transmucosal Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Transmucosal Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Transmucosal Drug Delivery Market Share by Regions (2016-2021)
Table 8. Global Transmucosal Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027)
Table 10. Transmucosal Drug Delivery Market Trends
Table 11. Transmucosal Drug Delivery Market Drivers
Table 12. Transmucosal Drug Delivery Market Challenges
Table 13. Transmucosal Drug Delivery Market Restraints
Table 14. Global Transmucosal Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Transmucosal Drug Delivery Market Share by Players (2016-2021)
Table 16. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020)
Table 17. Ranking of Global Top Transmucosal Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Transmucosal Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Transmucosal Drug Delivery Product Solution and Service
Table 21. Date of Enter into Transmucosal Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021)
Table 25. Global Transmucosal Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Transmucosal Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Transmucosal Drug Delivery Revenue Market Share by Application (2016-2021)
Table 29. Global Transmucosal Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Transmucosal Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Transmucosal Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Transmucosal Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transmucosal Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Transmucosal Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 61. 3M Pharmaceuticals Company Details
Table 62. 3M Pharmaceuticals Business Overview
Table 63. 3M Pharmaceuticals Transmucosal Drug Delivery Product
Table 64. 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 65. 3M Pharmaceuticals Recent Development
Table 66. Acrux Limited Company Details
Table 67. Acrux Limited Business Overview
Table 68. Acrux Limited Transmucosal Drug Delivery Product
Table 69. Acrux Limited Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 70. Acrux Limited Recent Development
Table 71. ALZA Corporation Company Details
Table 72. ALZA Corporation Business Overview
Table 73. ALZA Corporation Transmucosal Drug Delivery Product
Table 74. ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 75. ALZA Corporation Recent Development
Table 76. Antares Pharma, Inc. Company Details
Table 77. Antares Pharma, Inc. Business Overview
Table 78. Antares Pharma, Inc. Transmucosal Drug Delivery Product
Table 79. Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 80. Antares Pharma, Inc. Recent Development
Table 81. Apricus BioSciences, Inc Company Details
Table 82. Apricus BioSciences, Inc Business Overview
Table 83. Apricus BioSciences, Inc Transmucosal Drug Delivery Product
Table 84. Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 85. Apricus BioSciences, Inc Recent Development
Table 86. Aveva Drug Delivery Systems Company Details
Table 87. Aveva Drug Delivery Systems Business Overview
Table 88. Aveva Drug Delivery Systems Transmucosal Drug Delivery Product
Table 89. Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 90. Aveva Drug Delivery Systems Recent Development
Table 91. Corium International, Inc Company Details
Table 92. Corium International, Inc Business Overview
Table 93. Corium International, Inc Transmucosal Drug Delivery Product
Table 94. Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 95. Corium International, Inc Recent Development
Table 96. DURECT Corporation Company Details
Table 97. DURECT Corporation Business Overview
Table 98. DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 99. DURECT Corporation Recent Development
Table 100. Generex Biotechnology Corporation Company Details
Table 101. Generex Biotechnology Corporation Business Overview
Table 102. Generex Biotechnology Corporation Transmucosal Drug Delivery Product
Table 103. Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 104. Generex Biotechnology Corporation Recent Development
Table 105. Inovio Pharmaceuticals, Inc. Company Details
Table 106. Inovio Pharmaceuticals, Inc. Business Overview
Table 107. Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 108. Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 109. Inovio Pharmaceuticals, Inc. Recent Development
Table 110. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
Table 111. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
Table 112. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Product
Table 113. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 114. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
Table 115. MedPharm LTD Company Details
Table 116. MedPharm LTD Business Overview
Table 117. MedPharm LTD Transmucosal Drug Delivery Product
Table 118. MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 119. MedPharm LTD Recent Development
Table 120. Mylan, Inc. Company Details
Table 121. Mylan, Inc. Business Overview
Table 122. Mylan, Inc. Transmucosal Drug Delivery Product
Table 123. Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 124. Mylan, Inc. Recent Development
Table 125. Nemaura Pharma Ltd Company Details
Table 126. Nemaura Pharma Ltd Business Overview
Table 127. Nemaura Pharma Ltd Transmucosal Drug Delivery Product
Table 128. Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 129. Nemaura Pharma Ltd Recent Development
Table 130. Nitto Denko Corporation Company Details
Table 131. Nitto Denko Corporation Business Overview
Table 132. Nitto Denko Corporation Transmucosal Drug Delivery Product
Table 133. Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 134. Nitto Denko Corporation Recent Development
Table 135. Noven Pharmaceuticals, Inc. Company Details
Table 136. Noven Pharmaceuticals, Inc. Business Overview
Table 137. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Product
Table 138. Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 139. Noven Pharmaceuticals, Inc. Recent Development
Table 140. Pantec Biosolutions AG Company Details
Table 141. Pantec Biosolutions AG Business Overview
Table 142. Pantec Biosolutions AG Transmucosal Drug Delivery Product
Table 143. Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 144. Pantec Biosolutions AG Recent Development
Table 145. Tapemark Company Details
Table 146. Tapemark Business Overview
Table 147. Tapemark Transmucosal Drug Delivery Product
Table 148. Tapemark Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 149. Tapemark Recent Development
Table 150. tesa Labtec GmbH Company Details
Table 151. tesa Labtec GmbH Business Overview
Table 152. tesa Labtec GmbH Transmucosal Drug Delivery Product
Table 153. tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 154. tesa Labtec GmbH Recent Development
Table 155. TEVA Pharmaceutical Industries Ltd. Company Details
Table 156. TEVA Pharmaceutical Industries Ltd. Business Overview
Table 157. TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Product
Table 158. TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 159. TEVA Pharmaceutical Industries Ltd. Recent Development
Table 160. Zosano Pharma Company Details
Table 161. Zosano Pharma Business Overview
Table 162. Zosano Pharma Transmucosal Drug Delivery Product
Table 163. Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2016-2021) & (US$ Million)
Table 164. Zosano Pharma Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transmucosal Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Passive Transdermal Drug Delivery Features
Figure 3. Active Transdermal Drug Delivery Features
Figure 4. Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Transmucosal Drug Delivery Report Years Considered
Figure 9. Global Transmucosal Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Transmucosal Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Transmucosal Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 12. Global Transmucosal Drug Delivery Market Share by Regions (2022-2027)
Figure 13. Global Transmucosal Drug Delivery Market Share by Players in 2020
Figure 14. Global Top Transmucosal Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmucosal Drug Delivery as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Transmucosal Drug Delivery Revenue in 2020
Figure 16. Global Transmucosal Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 17. Global Transmucosal Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 18. North America Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 20. North America Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 21. North America Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 22. United States Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 26. Europe Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 27. Europe Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 28. Germany Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Transmucosal Drug Delivery Market Share by Region (2016-2027)
Figure 38. China Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 46. Latin America Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 47. Latin America Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 48. Mexico Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Transmucosal Drug Delivery Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Transmucosal Drug Delivery Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Transmucosal Drug Delivery Market Share by Country (2016-2027)
Figure 54. Turkey Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Transmucosal Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. 3M Pharmaceuticals Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 58. Acrux Limited Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 59. ALZA Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 60. Antares Pharma, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 61. Apricus BioSciences, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 62. Aveva Drug Delivery Systems Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 63. Corium International, Inc Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 64. DURECT Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 65. Generex Biotechnology Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 66. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 67. Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 68. MedPharm LTD Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 69. Mylan, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 70. Nemaura Pharma Ltd Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 71. Nitto Denko Corporation Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 72. Noven Pharmaceuticals, Inc. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 73. Pantec Biosolutions AG Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 74. Tapemark Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 75. tesa Labtec GmbH Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 76. TEVA Pharmaceutical Industries Ltd. Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 77. Zosano Pharma Revenue Growth Rate in Transmucosal Drug Delivery Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Keyplayers in Global and United States Transmucosal Drug Delivery Market Size, Status and Forecast 2021-2027
3M PharmaceuticalsAcrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma